J&J Loses Bid For New Trial In $482M Stent Patent Case

Law360, New York (September 21, 2011, 2:02 PM EDT) -- Johnson & Johnson on Tuesday suffered a blow in its battle to dodge a $482 million verdict against it for allegedly infringing a New Jersey radiologist’s coronary stent patent, with a Texas federal judge denying J&J’s request for a new trial.

The jury found in January that Johnson & Johnson and its subsidiary Cordis Corp. had willfully infringed Dr. Bruce N. Saffran's patent with its popular stent Cypher. In March, U.S. District Judge T. John Ward added $111 million in prejudgment interest to the verdict, bringing...
To view the full article, register now.